Randolph Sophia 4

4 · ALX ONCOLOGY HOLDINGS INC · Filed Dec 20, 2022

Form 4

Period: 2022-12-16

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2022-12-16$4.81/sh+25,339$121,881→ 271,870 total
Exercise/Conversion
Stock Option (right to buy)
2022-12-16−25,339→ 25,340 total
Exercise: $4.81Exp: 2030-04-27→ Common Stock (25,339 underlying)
Exercise/Conversion
Common Stock
2022-12-16$1.91/sh+8,404$16,052→ 233,800 total
Exercise/Conversion
Stock Option (right to buy)
2022-12-16−12,731→ 95,175 total
Exercise: $4.08Exp: 2030-03-09→ Common Stock (12,731 underlying)
Exercise/Conversion
Common Stock
2022-12-16$4.08/sh+12,731$51,942→ 246,531 total
Exercise/Conversion
Stock Option (right to buy)
2022-12-16−8,404→ 4,027 total
Exercise: $1.91Exp: 2029-09-12→ Common Stock (8,404 underlying)

Footnotes (3)

[F1]The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
[F2]The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
[F3]Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.

Documents

1 file